|
1
|
Patel RS, Ghasemzadeh N, Eapen DJ, Sher S,
Arshad S, Ko YA, Veledar E, Samady H, Zafari AM, Sperling L, et al:
Novel biomarker of oxidative stress is associated with risk of
death in patients with coronary artery disease. Circulation.
133:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vasilaki F, Tsitsimpikou C, Tsarouhas K,
Germanakis I, Tzardi M, Kavvalakis M, Ozcagli E, Kouretas D and
Tsatsakis AM: Cardiotoxicity in rabbits after long-term nandrolone
decanoate administration. Toxicol Lett. 241:143–151. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ungurianu A, Margină D, Grădinaru D,
Băcanu C, Ilie M, Tsitsimpikou C, Tsarouhas K, Spandidos DA and
Tsatsakis AM: Lipoprotein redox status evaluation as a marker of
cardiovascular disease risk in patients with inflammatory disease.
Mol Med Rep. 15:256–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andò G, Cortese B, Frigoli E, Gagnor A,
Garducci S, Briguori C, Rubartelli P, Calabrò P and Valgimigli M:
MATRIX investigators: Acute kidney injury after percutaneous
coronary intervention: Rationale of the AKI-MATRIX (acute kidney
injury-minimizing adverse hemorrhagic events by TRansradial access
site and systemic implementation of angioX) sub-study. Catheter
Cardiovasc Interv. 86:950–957. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andò G, Cortese B, Russo F, Rothenbühler
M, Frigoli E, Gargiulo G, Briguori C, Vranckx P, Leonardi S,
Guiducci V, et al: MATRIX Investigators: Acute kidney injury after
radial or femoral access for invasive acute coronary syndrome
management: AKI-MATRIX. J Am Coll Cardiol. 69:2592–2603. 2017.
View Article : Google Scholar
|
|
6
|
Kooiman J, Seth M, Dixon S, Wohns D,
LaLonde T, Rao SV and Gurm HS: Risk of acute kidney injury after
percutaneous coronary interventions using radial versus femoral
vascular access: Insights from the blue cross blue shield of
Michigan Cardiovascular Consortium. Circ Cardiovasc Interv.
7:190–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mamoulakis C, Tsarouhas K, Fragkiadoulaki
I, Heretis I, Wilks MF, Spandidos DA, Tsitsimpikou C and Tsatsakis
A: Contrast-induced nephropathy: Basic concepts, pathophysiological
implications and prevention strate gies. Pharmacol Ther.
180:99–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Katzberg RW and Newhouse JH: Intravenous
contrast medium-induced nephrotoxicity: Is the medical risk really
as great as we have come to believe? Radiology. 256:21–28. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
American College of Radiology: ACR
comittee on drugs and contrast media. ACR Manual on Contrast Media.
129:2016.
|
|
10
|
Burchardt P, Synowiec T, Jerzykowska S,
Angerer D and Żurawski J: Early renal dysfunction after iodine
contrast administration: New insight into the actual problem.
Kardiol Pol. 73:233–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burchardt P, Guzik P, Tabaczewski P,
Synowiec T, Bogdan M, Faner P, Chmielarz-Sobocińska A and Palasz A:
Early renal dysfunction after contrast media administration despite
prophylactic hydration. Int J Cardiovasc Imaging. 29:959–966. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schweiger MJ, Chambers CE, Davidson CJ,
Zhang S, Blankenship J, Bhalla NP, Block PC, Dervan JP, Gasperetti
C, Gerber L, et al: Prevention of contrast induced nephropathy:
recommendations for the high risk patient undergoing cardiovascular
procedures. Catheter Cardiovasc Interv. 69:135–140. 2007.https://doi.org/10.1002/ccd.20964
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
AlZadjali MA, Godfrey V, Khan F, Choy A,
Doney AS, Wong AK, Petrie JR, Struthers AD and Lang CC: Insulin
resistance is highly prevalent and is associated with reduced
exercise tolerance in nondiabetic patients with heart failure. J Am
Coll Cardiol. 53:747–753. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duncan MH, Singh BM, Wise PH, Carter G and
Alaghband-Zadeh J: A simple measure of insulin resistance. Lancet.
346:120–121. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsarouhas K, Tsitsimpikou C, Haliassos A,
Georgoulias P, Koutsioras I, Kouretas D, Kogias J, Liosis I,
Rentoukas E and Kyriakides Z: Study of insulin resistance, TNF-α,
total antioxidant capacity and lipid profile in patients with
chronic heart failure under exercise. In Vivo. 25:1031–1037.
2011.PubMed/NCBI
|
|
16
|
Tsamouri MM, Rapti M, Kouka P, Nepka C,
Tsarouhas K, Soumelidis A, Koukoulis G, Tsatsakis A, Kouretas D and
Tsitsimbikou C: Histopathological evaluation and redox assessment
in blood and kidney tissues in a rabbit contrast-induced
nephrotoxicity model. Food Chem Toxicol. 108:186–193.
2017.https://doi.org/10.1016/j.fct.2017.07.058
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Juni RP, Duckers HJ, Vanhoutte PM, Virmani
R and Moens AL: Oxidative stress and pathological changes after
coronary artery interventions. J Am Coll Cardiol. 61:1471–1481.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weinbrenner T, Cladellas M, Isabel Covas
M, Fitó M, Tomás M, Sentí M, Bruguera J and Marrugat J: High
oxidative stress in patients with stable coronary heart disease.
Atherosclerosis. 168:99–106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Sun YM, Wang LF, Li ZQ, Pan W and
Cao HY: Comparison of effects of simvastatin versus atorvastatin on
oxidative stress in patients with coronary heart disease. Clin
Cardiol. 33:222–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Wang W, Ma S, Lu J, Shi H and Ding
F: Reduced glutathione for prevention of renal outcomes in patients
undergoing selective coronary angiography or intervention. J Interv
Cardiol. 28:249–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kochiadakis GE, Arfanakis DA, Marketou ME,
Skalidis EI, Igoumenidis NE, Nikitovic D, Giaouzaki A, Chlouverakis
G and Vardas PE: Oxidative stress changes after stent implantation:
A randomized comparative study of sirolimus-eluting and bare metal
stents. Int J Cardiol. 142:33–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szewczyk-Golec K, Grzelakowski P, Lugowski
T and Kedziora J: The effects of percutaneous transluminal coronary
intervention on biomarkers of oxidative stress in the erythrocytes
of elderly male patients. Redox Rep. 22:315–322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ciçek D, Tamer L, Pekdemir H, Cin VG,
Yildirim H, Kara AA and Yurtdaş M: Coronary angioplasty induced
oxidative stress and its relation with metoprolol use and plasma
homocysteine levels. Anadolu Kardiyol Derg. 6:308–313.
2006.PubMed/NCBI
|
|
24
|
James MT, Ghali WA, Knudtson ML, Ravani P,
Tonelli M, Faris P, Pannu N, Manns BJ, Klarenbach SW and Hemmelgarn
BR: Alberta Provincial Project for Outcome Assessment in Coronary
Heart Disease (APPROACH) Investigators: Associations between acute
kidney injury and cardiovascular and renal outcomes after coronary
angiography. Circulation. 123:409–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCullough PA: Contrast-induced
nephropathy: Definitions, epidemiology, and implications. Interv
Cardiol Clin. 3:357–362. 2014.PubMed/NCBI
|
|
26
|
Börekçi A, Gür M, Türkoğlu C, Çaylı M,
Selek Ş, Kaypaklı O, Uçar H, Coşkun M, Şeker T, Koç M, et al:
Oxidative stress and paraoxonase 1 activity predict
contrast-induced nephropathy in patients with ST-segment elevation
myocardial infarction undergoing primary percutaneous coronary
intervention. Angiology. 66:339–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ribichini F, Graziani M, Gambaro G, Pasoli
P, Pighi M, Pesarini G, Abaterusso C, Yabarek T, Brunelleschi S,
Rizzotti P, et al: Early creatinine shifts predict contrast-induced
nephropathy and persistent renal damage after angiography. Am J
Med. 123:755–763. 2010. View Article : Google Scholar : PubMed/NCBI
|
